Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.

Literature DB >> 33811767

A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.

Hans C Lee¹, Lei Feng², Onyeka Oriabure¹, Vivian Graham¹, Wendy Chen¹, Maria Badillo¹, Rebecca Lu¹, Hun J Lee¹, Preetesh Jain¹, Elisabet E Manasanch¹, Robert Z Orlowski¹, Michael L Wang¹.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2021 PMID： 33811767 DOI： 10.1002/ajh.26178

Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047

× No keyword cloud information.

2 in total

1. Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group.

Authors: Norbert Grzasko; Grzegorz Charlinski; Marta Morawska; Pawel Kicinski; Anna Waszczuk-Gajda; Joanna Drozd-Sokolowska; Edyta Subocz; Danuta Blonska; Malgorzata Razny; Agnieszka Druzd-Sitek; Jadwiga Holojda; Alina Swiderska; Lidia Usnarska-Zubkiewicz; Anna Masternak; Krzysztof Giannopoulos
Journal: J Clin Med Date: 2021-11-24 Impact factor: 4.241

Review 2. Bendamustine: A review of pharmacology, clinical use and immunological effects (Review).

Authors: Hrvoje Lalic; Igor Aurer; Drago Batinic; Dora Visnjic; Tomislav Smoljo; Antonija Babic
Journal: Oncol Rep Date: 2022-05-04 Impact factor: 4.136

2 in total